SPI Initiative Powers Pharma Clusters & MSMEs with 500 Cr Support

Strengthening of Pharmaceutical Industry (SPI)' initiative, backed by Rs 500 crore (USD 60.9 million) provides vital support to enhance productivity, quality and sustainability across pharma clusters and MSMEs nationwide.

Highlighting the significance of this year's CPHI and PMEC India Expo, Yogesh Mudras, Managing Director, Informa Markets in India, said, "India's pharmaceutical industry, currently ranked third globally by production volume, has evolved into a thriving sector with a CAGR of 9.43 per cent over the past nine years. Known for delivering high-quality, affordable medicines, India has earned its reputation as the 'Pharmacy of the World'."

"Over the last 16 years, CPHI and PMEC India Expo has mirrored the industry's vision and growth. Now, as a key part of the world's largest global pharmaceutical community, it has transformed from a trade show into a robust platform for expanding business opportunities and delivering real-time industry insights, positioning us at the forefront of global pharmaceutical advancements," he added.

The 17th edition of the CPHI and PMEC expo showcasing the pharmaceutical industry's modernisation, innovation and sustainability will be held from November 26 to 28 in Greater Noida. The expo will showcase over 10,000 products, offering a unique space for collaboration and innovation in the pharma industry, said a release from the organiser Informa Markets in India.

The expo will this year offer a pivotal marketplace for over 2,000 exhibitors to engage with anticipated participation from countries, including the US, UAE, South Korea, Japan, Egypt, Vietnam, the Philippines, Malaysia, Italy, Sri Lanka, Bangladesh, Nepal, Iran, and the United Kingdom.